Jilin Yixin Pharmaceutical

Jilin Yixin Pharmaceutical is a comprehensive pharmaceutical company headquartered in Changchun, China, specializing in the research, development, and manufacturing of both Traditional Chinese Medicine (TCM) and modern chemical pharmaceuticals. The company's product portfolio is diverse, featuring treatments for cardiovascular diseases, respiratory infections, and metabolic disorders. Jilin Yixin operates state-of-the-art manufacturing facilities that adhere to national GMP standards, ensuring high-quality production of tablets, capsules, and granules. As a publicly traded entity on the NEEQ, the company leverages its strong R&D capabilities to modernize traditional herbal formulas and expand its footprint in the generic drug market. Their business model integrates raw material sourcing, advanced processing, and a robust domestic distribution network.